Related Experiment Video
Updated: Jan 14, 2026
Three-dimensional Rendering and Analysis of Immunolabeled, Clarified Human Placental Villous Vascular Networks
Published on: March 29, 2018
Risk Factors and Outcomes Associated With Delayed Villous Maturation in Placenta: A Systematic Review and
Muhammad Pradhiki Mahindra1,2, Muhammad Pradhika Mapindra2,3, Hadi Waheed1
1Maternal-Fetal Medicine Department, University College London Elizabeth Garrett Anderson Institute for Women's Health, London, UK.
Background:
Delayed villous maturation (DVM) is a placental maturation disorder that mainly affects maternal-to-foetal oxygen transfer.
Objectives:
We conducted a systematic review, meta-analysis, and sensitivity analysis exploring study heterogeneities (I2) of risk factors and outcomes associated with histopathological findings of DVM.
Search Strategy:
Medline, EMBASE, Web of Science, and MIDIRS databases were searched from inception to December 2023.
Selection Criteria:
Peer-reviewed, observational studies including cohort, case-control, and cross-sectional studies reported the histopathological findings of DVM after placenta delivery. All eligible studies were included and assessed for their risk of bias using the Newcastle-Ottawa scale (NOS) for cohort and case-control studies.
Data Collection And Analysis:
Two reviewers independently performed the systematic article screening, bias assessment, and data extraction. Senior authors resolved the disagreement between reviewers. The risk of bias was assessed by two reviewers using NOS criteria. The random-effects model was used for meta-analysis due to heterogeneity across studies. Sensitivity analyses were performed according to the NOS risk of bias assessment and the DVM definition per the Amsterdam criteria.
Main Results:
Fifty-two eligible studies reporting DVM and linked risk factors and outcomes were included. The risk factors associated with DVM were gestational diabetes (GDM) (OR = 4.90; 95% CI = 2.98, 8.06; I2 = 39%), pregestational diabetes (PGDM) (OR = 2.77; 95% CI = 1.56, 4.92; I2 = 0%), and maternal obesity (OR = 1.88; 95% CI = 1.20, 2.96; I2 = 0%). DVM was also associated with congenital foetal malformations (OR = 5.22; 95% CI =2.39, 11.39; I2 = 40), stillbirth (OR = 4.89; 95% CI = 3.55, 6.72; I2 = 0) and preterm birth (OR = 17.41; 95% CI = 10.14, 29.90; I2 = 0). The association between DVM and stillbirth (OR = 12.06; 95% CI =3.40, 42.78; I2 = 50; 2/5 studies) persisted in analyses limited to studies that used Amsterdam criteria exclusively for DVM.
Conclusion:
DVM is a placental abnormality associated with congenital foetal malformations and maternal dysmetabolism, including GDM, PGDM, and maternal obesity; and with adverse outcomes including stillbirth and preterm birth. In studies using Amsterdam criteria, placenta with DVM was associated with stillbirth and congenital malformations. Optimising metabolism could prevent harm to the baby.
More Related Videos
11:44A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta
Published on: September 27, 2017
12:17The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
Published on: August 2, 2017
